New York pharma firm paid $400m from Irish subsidiary

22nd December, 2014

A New York pharma firm paid more than $400 million in dividends from its Irish operations back to the US, just months before the firm was acquired, new filings reveal.

Forest Laboratories made the massive payments after recording a pre-tax profit of $426 million at its Irish unit in the financial year to the end of last March. The Irish company, Forest Laboratories Holdings, has notched up large profits in recent years, including almost $80 million...

Subscribe from just €1 for the first month!

Exclusive offers:

All Digital Access + eReader



Unlimited Access for 1 Month, €19.99 Monthly thereafter

Get basic

*New subscribers only

You can cancel any time.



€149 For the 1st Year

Unlimited Access for 1 Year

You can cancel any time.




90 Day Pass

You can cancel any time.

2 Yearly



Unlimited Access for 2 Years

You can cancel any time.

Team Pass

Get a Business Account for you and your team

Share this post

Related Stories

Susan O’Keeffe: The state is still failing mother and baby homes victims

Comment: Taking data as certain can lead to dangerous decisions

Data Diane Coyle 3 days ago

James O’Connor: Ireland could turn a higher rate of corporate tax into a win-win

Tax James O'Connor 4 days ago

Michael Brennan: Acid test of Greens’ peace deal will be what happens in Dublin Bay South

Home Michael Brennan 5 days ago